Article Text

other Versions

PDF
Multimodality imaging in congenital heart disease-related pulmonary arterial hypertension
  1. Michele D'Alto1,
  2. Konstantinos Dimopoulos2,
  3. Werner Budts3,
  4. Gerhard-Paul Diller4,
  5. Giovanni Di Salvo5,
  6. Santo Dellegrottaglie6,
  7. Pierluigi Festa7,
  8. Giancarlo Scognamiglio1,
  9. Gaetano Rea8,
  10. Lamia Ait Ali7,9,
  11. Wei Li2,
  12. Michael A Gatzoulis2
  1. 1Department of Cardiology, Second University of Naples, Monaldi Hospital, Naples, Italy
  2. 2Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton Hospital, London, UK
  3. 3Department of Cardiology, University Hospitals, Leuven, Belgium
  4. 4Department of Cardiology and Angiology, Adult Congenital and Valvular Heart Disease Center, University of Münster, Münster, Germany
  5. 5Department of Paediatric Cardiology, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia
  6. 6Division of Cardiology, “Villa dei Fiori” Accredited Private Hospital, Acerra, Naples, Italy
  7. 7Pediatric Cardiology and GUCH Unit, Fondazione G. Monasterio CNR-Regione Toscana, Massa-Pisa, Italy
  8. 8Department of Radiology, Monaldi Hospital, Naples, Italy
  9. 9Department of Cardiology, Institute of Clinical Physiology, CNR, Massa-Pisa, Italy
  1. Correspondence to Dr Michele D'Alto, Department of Cardiology, Second University of Naples, Monaldi Hospital, Via T. di Camaino, 6, Naples 80128, Italy; mic.dalto{at}tin.it

Abstract

Pulmonary arterial hypertension (PAH) in adult patients with congenital heart disease (CHD) is associated with increased morbidity and mortality. The present review aims to discuss the clinical applications of invasive and non-invasive diagnostic modalities and to describe the strengths and weaknesses of each technique. Chest radiograph is an inexpensive investigation providing information on pulmonary arterial and hilar dilatation, pruning of peripheral pulmonary arteries and cardiomegaly. Transthoracic two-dimensional and Doppler echocardiography is the most widely used imaging tool. It provides information on cardiac anatomy and an estimate of haemodynamics and biventricular remodelling and function. In addition, echocardiography is valuable in assessing prognosis and monitoring the efficacy of therapy. Structural and functional changes associated with CHD-PAH, mainly affecting the right ventricle and pulmonary circulation, may represent an ideal target for evaluation with cardiac magnetic resonance. This non-invasive imaging modality has a low biological impact. CT plays an important role for patients with limited echocardiographic windows and those who are unable to undergo MRI (claustrophobia, poor compliance, presence of a pacemaker/implantable cardioverter defibrillator). It is the modality of choice for detailed assessment of pulmonary vessel obstruction or thrombosis. Finally, heart catheterisation remains the gold standard for diagnosing and confirming PAH in patients with CHD and for shunt evaluation. The diagnostic assessment of CHD-PAH requires great expertise and a deep knowledge of both CHD and PAH pathophysiology and should take place in a tertiary centre, where multiple data can be appropriately integrated and applied clinically.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.